Morphic Holding Inc (MORF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MORF | AZN | AMGN | GILD | VRTX |
| Company | Morphic Holding Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 56.98 | 90.45 | 344.15 | 129.13 | 463.74 |
| High | 57.00 | 91.79 | 349.98 | 133.10 | 472.24 |
| Low | 56.97 | 90.17 | 342.14 | 129.00 | 458.31 |
| Latest | 56.99 | 91.64 | 348.95 | 131.79 | 472.37 |
| Change | +0.02 | +1.10 | +5.35 | +2.68 | +11.23 |
| % Change | +0.04% | +1.21% | +1.56% | +2.08% | +2.44% |
| Volume | 1,795,800 | 4,771,870 | 1,493,665 | 4,900,696 | 739,556 |
| 20-Day Average Volume | 1,792,620 | 8,116,698 | 2,248,494 | 5,615,733 | 1,245,033 |
| Previous Close | 56.97 | 90.54 | 343.60 | 129.11 | 461.14 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 56.76 | 93.05 | 331.14 | 123.66 | 457.87 |
| 20-Day Raw Stochastic | 98.46% | 34.40% | 95.28% | 90.84% | 70.36% |
| 20-Day Relative Strength | 79.44 | 50.25 | 62.84 | 61.66 | 58.11 |
| Weighted Alpha | +24.00 | +34.51 | +29.94 | +40.27 | +10.48 |
| Today's Opinion | 100% Buy | 80% Buy | 88% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 64% Buy | 88% Buy | 96% Buy | 72% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 72% Buy | 88% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.19% since 08/08/24 | -4.91% since 01/14/26 | +5.93% since 01/14/26 | +6.08% since 01/14/26 | +4.59% since 01/14/26 |
| Low | 56.89 on 08/09/24 | 89.04 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 429.00 on 01/20/26 |
| High | 57.00 on 08/15/24 | 95.36 on 01/15/26 | 349.98 on 01/22/26 | 133.10 on 01/22/26 | 472.24 on 01/22/26 |
| 1-Month | |||||
| %Chg | +1.90% since 07/15/24 | +0.07% since 12/22/25 | +5.16% since 12/22/25 | +6.00% since 12/22/25 | +2.14% since 12/22/25 |
| Low | 55.91 on 07/16/24 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 57.00 on 08/15/24 | 96.51 on 01/07/26 | 349.98 on 01/22/26 | 133.10 on 01/22/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +88.52% since 05/15/24 | +9.80% since 10/22/25 | +17.74% since 10/22/25 | +8.36% since 10/22/25 | +10.26% since 10/22/25 |
| Low | 25.25 on 06/18/24 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 57.00 on 08/15/24 | 96.51 on 01/07/26 | 349.98 on 01/22/26 | 133.10 on 01/22/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +47.45% since 02/15/24 | +29.98% since 07/22/25 | +14.00% since 07/22/25 | +19.47% since 07/22/25 | +0.01% since 07/22/25 |
| Low | 25.25 on 06/18/24 | 71.49 on 07/28/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 57.00 on 08/15/24 | 96.51 on 01/07/26 | 349.98 on 01/22/26 | 133.10 on 01/22/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,854,857 | 280,838,432 | 185,022,080 | 160,184,192 | 116,999,984 |
| Shares Outstanding, K | 50,094 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 520,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -152,100,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -57,590,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.49 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.15 on 07/25/24 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/01/24 | 02/10/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.68 | 15.13 | 15.16 | 28.88 |